Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus - Wikidata - wikimedia - TriplyDB

Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus

Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus

http://www.wikidata.org/entity/Q24816281

about

Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage Chronic hepatitis C and liver fibrosis.Hyaluronic Acid: from biochemical characteristics to its clinical translation in assessment of liver fibrosis Prediction of Post-Operative Liver Dysfunction by Serum Markers of Liver Fibrosis in Hepatocellular Carcinoma Induction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients.Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C.Liver elastography, comments on EFSUMB elastography guidelines 2013.Non-invasive assessment of liver fibrosis in chronic hepatitis C.A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives.Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients?Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients.Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study.Safety and efficacy of Qurse-e-istisqua in chronic hepatitis C infection: an exploratory study Determination of the relationship of serum hyaluronic Acid levels to the degree of liver fibrosis in biopsies of patients with chronic viral hepatitis B and C.Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy Evaluation of the biomarker candidate MFAP4 for non-invasive assessment of hepatic fibrosis in hepatitis C patients.Human Recombinant Hyaluronidase Injections For Upper Limb Muscle Stiffness in Individuals With Cerebral Injury: A Case Series.Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms.Liver fibrosis staging through a stepwise analysis of non-invasive markers (FibroSteps) in patients with chronic hepatitis C infection Serum hyaluronic acid as a noninvasive marker of hepatic fibrosis in chronic hepatitis B Hyaluronic acid concentration in liver diseases.Assessing liver fibrosis.Evaluation of the relation between hepatic fibrosis and basic laboratory parameters in patients with chronic hepatitis B fibrosis and basic laboratory parameters Non-invasive assessment of liver fibrosis: it is time for laboratory medicine.Diagnosis and Management of Hepatitis C Virus Infection.Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study.Transcriptional profiling and co-expression network analysis identifies potential biomarkers to differentiate chronic hepatitis B and the caused cirrhosis.Hyaluronan's Role in Fibrosis: A Pathogenic Factor or a Passive Player?Sinusoidal communication in liver fibrosis and regeneration.Malondialdehyde; Lipid peroxidation plasma biomarker correlated with hepatic fibrosis in human Schistosoma mansoni infection.Spotlight on the three main hepatic fibrogenic cells in HCV-infected patients: Multiple immunofluorescence and ultrastructure study.Comparison of relationship between histopathological, serological and biochemical parameters in patients with chronic hepatitis B infection.Non-invasive assessment of liver fibrosis in chronic viral hepatitis.How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?Serum hyaluronic acid: a promising marker of hepatic fibrosis in chronic hepatitis B.Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis.Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients.

P2860

Q26752723-FC7C3AF9-EFCF-4241-9A8E-42C7322447D0 Q26773289-CAA623FB-9BE5-4A98-9DCE-1C9A332A75E2 Q26825671-437EFCCF-66C1-45F4-8410-B213D7E27F70 Q27021754-7E3172FE-15AB-432D-BB22-B846B9BD9638 Q28550484-79B0864A-CEAE-45EE-81A9-723BEC33BFA4 Q30357883-7DD16F76-1067-4D85-8075-579A7744B66A Q30375016-D2F09DE4-A5E3-4324-A735-83B26901DFC9 Q30448132-84690D90-B5C3-4B30-9037-E11E18BB9E69 Q30474738-941636F8-F353-40DD-B7E4-9FC19C5BBBE9 Q30476922-678283BD-12DE-4440-9CEC-ABB1433CB55D Q33556551-71EC6A5A-A81D-4650-8A90-C6C3516B60BE Q33665359-9B329DB1-ACE0-4063-AFD9-38511E1BE959 Q33866383-5A4AC3B6-D7C6-4737-9C57-308F2B7A24DC Q34749550-5F657887-4F57-418B-BDDE-50185CE4D4E8 Q35156330-D82C1D0E-3471-47C0-B747-15710F7B0226 Q35222402-E8D3DBBE-4133-45F5-8D84-427880C63DBE Q35714938-474BCC3A-7629-471F-B89B-10885980B13C Q35791614-2455A4ED-6DE4-4AC5-B03F-3C2E58111CA7 Q37064540-FBC71AF0-CBCC-4687-93B6-AFDB9436C145 Q37149831-686C5A3A-C4F5-4A97-B1E8-74DAAFAC75B5 Q37192623-F63FD50B-FBA6-4EA8-A0E7-4F72DABC8892 Q37222778-7FA67DB8-82A2-42C8-990E-F13723B47E12 Q37243587-DA31F6FA-A9C1-4522-BFD9-CB5A32F5C10C Q37338746-21E04D9D-C438-4F52-A295-036DFD7DBFF7 Q37345958-7972A7F6-FA8F-45FB-9A21-DA11DE597C10 Q37707436-4672CB47-A812-4D47-BBC7-235304E8EC29 Q37801658-7C5AAEAE-7B1F-47BA-A637-B5433372AF0B Q38327430-98440616-2248-4640-BD29-43E5F644054C Q38407281-107826B5-F99C-467F-B5EB-0922CBD7CF20 Q38479037-2F1D173B-A35C-4DDE-8B11-DAC5DCFFDD01 Q38638213-755E0BAB-37C0-4D4D-9CAA-4393715674FB Q38827092-07285222-CD9E-44B0-8582-802881FD9209 Q38885879-A9B5B589-15C5-43AA-B315-A536350F170E Q40615522-1FDCF45F-FE9E-4897-AED6-86F159714C60 Q40678115-DC74D4F7-CFA0-47B1-BF63-D98A87E605A0 Q41278105-EC4C49BE-C9DC-4043-AB45-D5DC7367E9F7 Q43046834-1183EBC6-D04A-4D89-9DD3-F65B9F56A2A4 Q43095287-873BA117-045C-4F45-B74B-A714CB14D53F Q44028417-B3B3A0C2-05AD-4BA6-B165-FB10EF0E4FDF Q44590666-C6D1B445-48B7-42D7-9802-966E7B3DD51F

P2860

Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus

http://www.wikidata.org/entity/Q24816281

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Accuracy of hyaluronic acid le ...... atients with hepatitis C virus

@ast

Accuracy of hyaluronic acid le ...... atients with hepatitis C virus

@en

Accuracy of hyaluronic acid le ...... atients with hepatitis C virus

@nl

type

label

Accuracy of hyaluronic acid le ...... atients with hepatitis C virus

@ast

Accuracy of hyaluronic acid le ...... atients with hepatitis C virus

@en

Accuracy of hyaluronic acid le ...... atients with hepatitis C virus

@nl

prefLabel

Accuracy of hyaluronic acid le ...... atients with hepatitis C virus

@ast

Accuracy of hyaluronic acid le ...... atients with hepatitis C virus

@en

Accuracy of hyaluronic acid le ...... atients with hepatitis C virus

@nl

P1433

Q24816281-5C1A7A40-7C04-4DB3-8979-E001A220744F

P1476

Q24816281-C957B71E-E532-4355-A6EB-A3ADAD2FE05A

P2093

Q24816281-2133D51A-4EAA-4005-807C-8778A5614F86

Q24816281-353275D5-9CDE-4E4A-9D19-FD7BCE29BD23

Q24816281-591A56FE-5183-4F36-A247-5F75A9A56358

Q24816281-6D2BA43F-9B36-4DA6-8BB9-5D41504F29A0

Q24816281-7160FB27-0193-4850-82AD-40A01A3B6CAD

Q24816281-7402BEE3-895B-426C-A7A9-15ACD32D3567

Q24816281-75EAA23D-A135-4673-BFC7-4429BEAAD19B

Q24816281-958085BF-CC8B-4394-8FE0-080325C6658C

Q24816281-A7FB571E-895C-4CC5-9B11-D327423D22D9

Q24816281-F0FDEE37-148C-4C6A-BE88-D25BC113B6FD

P2860

Q24816281-08AAAA25-1225-40B0-81FB-27FE92DE737F

Q24816281-0CC812CC-9520-472B-B126-1726CED162DF

Q24816281-1C07442B-543F-4BE3-BC7B-D09C38753BDB

Q24816281-407CBC0E-7A0A-479B-A9E3-18B7A94BDFC5

Q24816281-4E69B079-EF70-490E-B403-02021CB0F6F8

Q24816281-4EBBB8F4-6712-46BE-B42C-1D1B30DA9542

Q24816281-55E961DE-C4D4-4951-966F-1404621A376B

Q24816281-736B3E92-2142-4C0B-9FBF-A14D9573BBAC

Q24816281-7A0A016B-37CE-414A-869D-3D22380FB5E8

Q24816281-932594ED-F2EF-4C1C-A39C-C58BAA7DD528

P2888

Q24816281-8413FE92-4E34-4C98-B1D5-A2F7C49951F4

P304

Q24816281-5927A3AC-FA3D-452D-9BEA-725AB5881BDB

P31

Q24816281-2758CBA6-F9CC-4B10-8DAB-E9629D3EE773

P3181

Q24816281-8CBA6273-71D2-4154-8E4F-3109D7158015

P356

Q24816281-EE73440F-4D17-479E-9049-D34035F76481

P407

Q24816281-F81C3974-86E5-4DD2-B5D5-A9A73A4FD89D

P433

Q24816281-52426879-A4EE-4054-8413-28CA8BD1791D

P478

Q24816281-A3EEDC06-58CE-4CE0-B093-ED9764A7F270

P50

Q24816281-C51FA909-8657-4084-9170-B84ECD499114

P577

Q24816281-E843703C-B2E8-4B1C-B3A7-C8B05DD541E7

P5875

Q24816281-27FAB90B-BFE1-4EB7-84E3-FFF2BE85FBAD

P6179

Q24816281-A832C035-C574-4AAB-911D-AAA77F1978A5

P698

Q24816281-19811178-8FF1-4745-8BAA-F910979B087D

P921

Q24816281-F7421832-241E-404F-BC09-99B394DCFD24

P932

Q24816281-32B2CA30-0C5E-47A9-9694-1703D691A7C7

P3181

P356

P1433

Comparative Hepatology

P1476

Accuracy of hyaluronic acid le ...... atients with hepatitis C virus

@en

P2093

Albert Tran

http://www.w3.org/2001/XMLSchema#string

Alessandra Rosenthal-Allieri

http://www.w3.org/2001/XMLSchema#string

Christophe Renou

http://www.w3.org/2001/XMLSchema#string

Danielle Botta-Fridlund

http://www.w3.org/2001/XMLSchema#string

Denis Ouzan

http://www.w3.org/2001/XMLSchema#string

Isabelle Allemand

http://www.w3.org/2001/XMLSchema#string

Isabelle Portal

http://www.w3.org/2001/XMLSchema#string

Marc Bourlière

http://www.w3.org/2001/XMLSchema#string

Philippe Halfon

http://www.w3.org/2001/XMLSchema#string

Romaric Deydier

http://www.w3.org/2001/XMLSchema#string

P2860

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection.

Grading and staging of hepatic fibrosis, and its relationship with noninvasive diagnostic parameters

Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.

Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue.

Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy.

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

Serum hyaluronan and aminoterminal propeptide of type III procollagen: variation with age.

P2888

P304

6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

271675

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1476-5926-4-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Guillaume Penaranda

P577

2005-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7735434

http://www.w3.org/2001/XMLSchema#string

P6179

1000705516

http://www.w3.org/2001/XMLSchema#string

P698

16008833

http://www.w3.org/2001/XMLSchema#string

P921

P932

1192814

http://www.w3.org/2001/XMLSchema#string